GSK-SAM101667

Study Sponsor: GSK

Study Title

A multicentre, randomised, double-blind, parallel group study to compare the efficacy and safety of Salmeterol/Fluticasone propionate combination product (Seretide®) 50/100 mcg with Fluticasone propionate (Flixotide® ) 200 mcg, both delivered twice daily via the DISKUS inhaler, in the treatment of children aged 6-12 years with symptomatic asthma

Medicine or Vaccine (generic name)

fluticasone propionate/salmeterol

Sponsor Identification Number

SAM101667

Trial Registry Identification Number(#'s)

NCT00197106 2004-002456-33

Medical Condition

Asthma

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=SAM101667

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00197106

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2004-002456-33

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An analysis-ready dataset is not available for this study. Only limited raw data are available for this study.

Date Added to this Site

March 2018